迪安诊断
(300244)
| 流通市值：104.10亿 | | | 总市值：129.75亿 |
| 流通股本：5.01亿 | | | 总股本：6.25亿 |
| 利润表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 营业总收入 | 2,246,960,355.26 | 10,096,031,634.52 | 7,565,586,728.42 | 4,936,484,994.33 |
| 营业总成本 | 2,058,243,891.81 | 9,550,980,754.99 | 7,011,768,898.52 | 4,643,502,517.31 |
| 其他经营收益 | | | | |
| 营业利润 | 156,727,703.83 | 281,315,361.51 | 285,029,731.7 | 115,852,951.72 |
| 利润总额 | 154,682,120.53 | 256,189,820.63 | 276,089,133.22 | 110,799,677.17 |
| 净利润 | 104,215,987.89 | 145,606,236.85 | 182,010,837.3 | 82,202,775.66 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 104,215,987.89 | 145,606,236.85 | 182,010,837.3 | 82,202,775.66 |
| 资产负债表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 流动资产: | | | | |
| 流动资产合计 | 10,590,908,768.56 | 10,863,595,804.78 | 11,040,261,948.58 | 11,273,221,654.15 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,487,485,663.94 | 3,558,831,529.48 | 3,724,754,815.65 | 3,811,260,491.5 |
| 资产总计 | 14,078,394,432.5 | 14,422,427,334.26 | 14,765,016,764.23 | 15,084,482,145.65 |
| 流动负债: | | | | |
| 流动负债合计 | 3,874,471,017.76 | 4,088,848,856.74 | 4,031,514,716.69 | 4,207,160,090.65 |
| 非流动负债: | | | | |
| 非流动负债合计 | 1,539,636,924.11 | 1,729,233,737.55 | 2,059,282,888.96 | 2,280,223,540.23 |
| 负债合计 | 5,414,107,941.87 | 5,818,082,594.29 | 6,090,797,605.65 | 6,487,383,630.88 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 6,526,797,980.18 | 6,442,461,924.28 | 6,469,719,556.3 | 6,423,291,951.49 |
| 股东权益合计 | 8,664,286,490.63 | 8,604,344,739.97 | 8,674,219,158.58 | 8,597,098,514.77 |
| 负债和股东权益合计 | 14,078,394,432.5 | 14,422,427,334.26 | 14,765,016,764.23 | 15,084,482,145.65 |
| 现金流量表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,236,380,777.96 | 12,431,032,951.42 | 8,468,610,339.97 | 5,457,373,590.98 |
| 经营活动现金流出小计 | 2,400,113,130.63 | 10,402,700,079.9 | 7,596,894,716.87 | 5,179,665,006.9 |
| 经营活动产生的现金流量净额 | -163,732,352.67 | 2,028,332,871.52 | 871,715,623.1 | 277,708,584.08 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 148,507,602.09 | 614,304,229.18 | 382,954,530.55 | 286,088,037.32 |
| 投资活动现金流出小计 | 263,519,581.89 | 939,870,088.87 | 706,220,266.62 | 397,611,649.61 |
| 投资活动产生的现金流量净额 | -115,011,979.8 | -325,565,859.69 | -323,265,736.07 | -111,523,612.29 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 160,326,411.46 | 1,491,937,924.48 | 1,258,344,756.53 | 866,640,669.38 |
| 筹资活动现金流出小计 | 363,493,359.85 | 2,882,249,607.48 | 2,247,797,547.96 | 1,378,985,493.25 |
| 筹资活动产生的现金流量净额 | -203,166,948.39 | -1,390,311,683 | -989,452,791.43 | -512,344,823.87 |
| 汇率变动对现金及现金等价物的影响 | -2,790,878.81 | -4,402,570.35 | -2,315,345.42 | -925,032.38 |
| 现金及现金等价物净增加额 | -484,702,159.67 | 308,052,758.48 | -443,318,249.82 | -347,084,884.46 |
| 期末现金及现金等价物余额 | 1,613,483,545.06 | 2,098,185,704.73 | 1,346,814,696.43 | 1,443,048,061.79 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 308,052,758.48 | - | -347,084,884.46 |
最新报告期：2026-05-20| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中泰证券 | 祝嘉琦,谢木青 | 0.76 | 0.82 | 0.92 | 2026-05-20 |